Ibandronic acid
Sold as Bondronat, Boniva, Sandoz ibandronate, Bonate, Phosic, Bonrix
[1-Hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphonic acid
Drag to rotate. Structure from PubChem CID 60852.
Background
Registration
- Applicants
- 4
- Registrations
- 13
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Adcock ingram limited | Bondronat, Boniva | 2 mg/ 2 ml, 3 mg/3 ml, 6 mg/6 ml, 50 mg, 150 mg | 320114, 410526, 410527, A380381, A380562 | S4 | PIPIL |
| Oethmaan Biosims (Pty) Ltd | Sandoz ibandronate | 2 mg/2 ml, 6 mg/6 ml | 440258, 440259 | S4 | None |
| Sandoz South Africa (Pty) LtdCancelled | Bonate | 2 mg/2 ml, 6 mg/6 ml | 440319, 440320 | S4 | None |
| Accord Healthcare (Pty) Ltd | Phosic, Bonrix | 2 mg/2 ml, 6 mg/6 ml | 490581, 490582, 490583, 490584 | S4 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Bondronat 2 mg/ 2 ML EACH 1,0 ml SOLUTION CONTAINS IBANDRONIC ACID 1,0 mg | 2 mg/ 2 ml | 32011432/3.2/0114 | Registered | S4 | None |
| Boniva 3 mg/3 ML EACH PRE-FILLED SYRINGE CONTAINS IBANDRONIC ACID MONOSODIUM EQUIVALENT TO IBANDRONIC ACID 3,0 mg | 3 mg/3 ml | 41052641/3.2/0526 | Registered | S4 | None |
| Boniva 150 MG EACH TABLET CONTAINS IBANDRONIC ACID MONOSODIUM EQUIVALENT TO IBANDRONIC ACID 150,0 mg | 150 mg | 41052741/3.2/0527 | Registered | S4 | None |
| Sandoz ibandronate 2 mg/2 ML EACH AMPOULE CONTAINS IBANDRONIC ACID 2,0 mg | 2 mg/2 ml | 44025844/3.2/0258 | Registered | S4 | None |
| Sandoz ibandronate 6 mg/6 ML EACH VIAL CONTAINS IBANDRONIC ACID 6,0 mg | 6 mg/6 ml | 44025944/3.2/0259 | Registered | S4 | None |
| Bonate 2 mg/2 ML EACH AMPOULE CONTAINS IBANDRONIC ACID 2,0 mg | 2 mg/2 ml | 44031944/3.2/0319 | Cancelled | S4 | None |
| Bonate 6 mg/6 ML EACH VIAL CONTAINS IBANDRONIC ACID 6,0 mg | 6 mg/6 ml | 44032044/3.2/0320 | Cancelled | S4 | None |
| Phosic 2 mg/2 ML Each 2,0 ml Solution contains: Ibandronic Acid 2,0 mg | 2 mg/2 ml | 49058149/3.2/0581 | Registered | S4 | None |
| Phosic 6 mg/6 ML Each 6,0 ml Solution contains: Ibandronic Acid 6,0 mg | 6 mg/6 ml | 49058249/3.2/0582 | Registered | S4 | None |
| Bonrix 2 mg/2 ML EACH 2,0 ml SOLUTION CONTAINS: IBANDRONIC ACID 2,0 mg | 2 mg/2 ml | 49058349/3.2/0583 | Registered | S4 | None |
| Bonrix 6 mg/6 ML EACH 6,0 ml SOLUTION CONTAINS: IBANDRONIC ACID 6,0 mg | 6 mg/6 ml | 49058449/3.2/0584 | Registered | S4 | None |
| Bondronat 6 mg/6 ML EACH VIAL CONTAINS IBANDRONIC ACID 6,0 mg | 6 mg/6 ml | A380381A38/3.2/0381 | Registered | S4 | None |
| Bondronat 50 EACH TABLET CONTAINS IBANDRONIC ACID 50,0 mg | 50 mgFilm-coated tablets. | A380562A38/3.2/0562Approved 5 January 2026 | Registered | S4 | PIPIL |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Ibandronic acid
S4: Ibandronic acid
Consolidated Schedules 06 July 2026, line 6658
Pharmacological class: Non-hormonal preparations. (class 3.2)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Bondronat 50, Adcock ingram limited is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.